Skip to main content
BRIGHT MINDS BIOSCIENCES INC. logo

BRIGHT MINDS BIOSCIENCES INC. — Investor Relations & Filings

Ticker · DRUG ISIN · CA10919W1086 US Manufacturing
Filings indexed 158 across all filing types
Latest filing 2026-02-17 Major Shareholding Noti…
Country US United States of America
Listing US DRUG

About BRIGHT MINDS BIOSCIENCES INC.

https://brightmindsbio.com/

Bright Minds Biosciences Inc. is a biotechnology company developing novel treatments for neurological and psychiatric disorders. The company's approach focuses on healing the central nervous system and brain through the regulation of serotonin. Using a proprietary chemistry platform, Bright Minds develops highly selective serotonin receptor agonists, specifically targeting 5-HT2A and 5-HT2C receptors while avoiding 5-HT2B activity to improve the safety profile of its drug candidates. Its therapeutic pipeline addresses conditions such as epilepsy, neuropsychiatric disorders, and pain, with dedicated programs for rare diseases like Prader-Willi Syndrome.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-06 English
FORM 6-K
Foreign Filer Report
2026-01-09 English
FORM 6-K
Foreign Filer Report
2026-01-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.